113 related articles for article (PubMed ID: 9545367)
1. Should all people over the age of 50 have regular fecal occult-blood tests? Postpone population screening until problems are solved.
Simon JB
N Engl J Med; 1998 Apr; 338(16):1151-2; discussion 1154-5. PubMed ID: 9545367
[No Abstract] [Full Text] [Related]
2. Fecal occult blood testing: clinical value and limitations.
Simon JB
Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
[TBL] [Abstract][Full Text] [Related]
4. Should all people over the age of 50 have regular fecal occult-blood tests? If it works, why not do it?
Fletcher RH
N Engl J Med; 1998 Apr; 338(16):1153-4; discussion 1154-5. PubMed ID: 9547141
[No Abstract] [Full Text] [Related]
5. Role of fecal occult-blood testing.
Bond JH; Mandel JS; Church TR
N Engl J Med; 1998 Sep; 339(11):774-5. PubMed ID: 9742033
[No Abstract] [Full Text] [Related]
6. Limitations of the faecal occult blood test in screening for colorectal cancer.
Delcò F; Sonnenberg A
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
[TBL] [Abstract][Full Text] [Related]
7. Digital rectal fecal occult blood screening during gynecologic examination.
Willis FL; Fanning J
Am J Obstet Gynecol; 2004 May; 190(5):1422-3. PubMed ID: 15167856
[TBL] [Abstract][Full Text] [Related]
8. The case for population-based screening for colorectal cancer.
Schoen RE
Nat Rev Cancer; 2002 Jan; 2(1):65-70. PubMed ID: 11902587
[TBL] [Abstract][Full Text] [Related]
9. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
10. Population colorectal cancer screening with fecal occult blood test.
Rennert G; Rennert HS; Miron E; Peterburg Y
Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1165-8. PubMed ID: 11700264
[TBL] [Abstract][Full Text] [Related]
11. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods.
Yamamoto M; Nakama H
Hepatogastroenterology; 2000; 47(32):396-9. PubMed ID: 10791199
[TBL] [Abstract][Full Text] [Related]
13. The effect of fecal occult-blood screening on the incidence of colorectal cancer.
Ransohoff DF; Pignone M
N Engl J Med; 2001 Mar; 344(13):1022-3. PubMed ID: 11280325
[No Abstract] [Full Text] [Related]
14. [Colorectal cancer screening should be evaluated in Swedish studies].
Blom J
Lakartidningen; 2008 Sep 17-23; 105(38):2564-7. PubMed ID: 18846858
[No Abstract] [Full Text] [Related]
15. Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence.
Grazzini G; Ciatto S; Cislaghi C; Castiglione G; Falcone M; Mantellini P; Zappa M;
J Med Screen; 2008; 15(4):175-81. PubMed ID: 19106257
[TBL] [Abstract][Full Text] [Related]
16. Fecal-occult-blood test screening for colorectal cancer.
Zacks M
J Fam Pract; 1997 Mar; 44(3):247-8. PubMed ID: 9071239
[No Abstract] [Full Text] [Related]
17. Screen compliance rates in 14-years annual screening program for colorectal cancer with immunochemical fecal occult blood test-- identification of higher priority subjects in health education.
Wei N; Nakama H; Li T
Eur J Med Res; 1998 Jul; 3(7):341-4. PubMed ID: 9682030
[TBL] [Abstract][Full Text] [Related]
18. Screening for colorectal cancer using faecal blood testing: varying the positive cut-off value.
Edwards JB
Pathology; 2005 Dec; 37(6):565-8. PubMed ID: 16373240
[No Abstract] [Full Text] [Related]
19. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer screening.
Cher DJ
J Public Health Med; 1993 Jun; 15(2):211-2. PubMed ID: 8353013
[No Abstract] [Full Text] [Related]
[Next] [New Search]
